Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 38 | 2023 | 4567 | 1.780 |
Why?
|
Coronary Stenosis | 16 | 2022 | 834 | 1.580 |
Why?
|
Coronary Artery Disease | 35 | 2023 | 6454 | 1.510 |
Why?
|
Plaque, Atherosclerotic | 19 | 2023 | 1499 | 1.280 |
Why?
|
Chest Pain | 15 | 2022 | 1113 | 1.110 |
Why?
|
Acute Coronary Syndrome | 17 | 2024 | 2337 | 1.000 |
Why?
|
Coronary Vessels | 12 | 2023 | 3099 | 0.770 |
Why?
|
Diagnosis | 2 | 2017 | 154 | 0.700 |
Why?
|
Therapeutics | 1 | 2017 | 116 | 0.600 |
Why?
|
Angina Pectoris | 5 | 2019 | 977 | 0.550 |
Why?
|
Ebolavirus | 1 | 2017 | 263 | 0.490 |
Why?
|
Risk | 2 | 2017 | 9679 | 0.450 |
Why?
|
Probability | 1 | 2017 | 2502 | 0.420 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 428 | 0.410 |
Why?
|
Troponin I | 4 | 2022 | 619 | 0.390 |
Why?
|
Models, Theoretical | 5 | 2020 | 3584 | 0.360 |
Why?
|
Predictive Value of Tests | 25 | 2023 | 15056 | 0.340 |
Why?
|
Risk Assessment | 26 | 2023 | 23320 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2020 | 3239 | 0.310 |
Why?
|
Tomography, X-Ray Computed | 16 | 2023 | 20086 | 0.290 |
Why?
|
Exercise Test | 3 | 2020 | 2075 | 0.290 |
Why?
|
Managed Competition | 1 | 2006 | 34 | 0.290 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2020 | 279 | 0.280 |
Why?
|
Models, Economic | 2 | 2019 | 713 | 0.240 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15108 | 0.240 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1265 | 0.230 |
Why?
|
Myocardial Infarction | 7 | 2022 | 11690 | 0.220 |
Why?
|
National Health Programs | 1 | 2006 | 445 | 0.220 |
Why?
|
Financing, Government | 1 | 2006 | 468 | 0.220 |
Why?
|
Troponin | 2 | 2024 | 524 | 0.220 |
Why?
|
Risk Adjustment | 1 | 2006 | 594 | 0.220 |
Why?
|
Myocardial Revascularization | 3 | 2020 | 841 | 0.210 |
Why?
|
Atherosclerosis | 3 | 2023 | 3428 | 0.200 |
Why?
|
Middle Aged | 52 | 2024 | 213127 | 0.200 |
Why?
|
HIV Infections | 6 | 2023 | 16678 | 0.190 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 143 | 0.190 |
Why?
|
Prognosis | 18 | 2023 | 29010 | 0.190 |
Why?
|
Decision Making | 2 | 2015 | 3869 | 0.180 |
Why?
|
Cardiac Volume | 1 | 2021 | 210 | 0.180 |
Why?
|
Risk Factors | 27 | 2023 | 72145 | 0.180 |
Why?
|
Adipose Tissue | 4 | 2023 | 3278 | 0.180 |
Why?
|
Male | 54 | 2024 | 349538 | 0.160 |
Why?
|
Pericardium | 2 | 2020 | 667 | 0.160 |
Why?
|
Female | 53 | 2024 | 379592 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 131 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 817 | 0.140 |
Why?
|
Coronary Care Units | 1 | 2016 | 214 | 0.130 |
Why?
|
Humans | 64 | 2024 | 742088 | 0.130 |
Why?
|
Logic | 1 | 2015 | 39 | 0.130 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 1993 | 41 | 0.120 |
Why?
|
Aspirin | 2 | 2015 | 3278 | 0.110 |
Why?
|
Prospective Studies | 15 | 2022 | 53187 | 0.110 |
Why?
|
Carotid Arteries | 1 | 2017 | 952 | 0.110 |
Why?
|
Calcium | 5 | 2023 | 5753 | 0.100 |
Why?
|
Aged | 24 | 2022 | 162944 | 0.100 |
Why?
|
Cholelithiasis | 1 | 1993 | 411 | 0.100 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 1993 | 224 | 0.100 |
Why?
|
Cholecystectomy | 1 | 1993 | 387 | 0.100 |
Why?
|
Rupture, Spontaneous | 3 | 2018 | 354 | 0.100 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 882 | 0.100 |
Why?
|
Electrocardiography | 4 | 2017 | 6440 | 0.100 |
Why?
|
Emergency Service, Hospital | 4 | 2019 | 7645 | 0.090 |
Why?
|
Gallstones | 1 | 1993 | 286 | 0.090 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15530 | 0.090 |
Why?
|
Reproducibility of Results | 9 | 2021 | 19862 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2857 | 0.090 |
Why?
|
Troponin T | 1 | 2015 | 749 | 0.090 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 1991 | 89 | 0.090 |
Why?
|
Triage | 1 | 2016 | 977 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
Dyspnea | 1 | 2017 | 1298 | 0.090 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3611 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2015 | 555 | 0.090 |
Why?
|
Intraoperative Care | 1 | 1993 | 766 | 0.090 |
Why?
|
Colonic Diseases | 1 | 1991 | 202 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1884 | 0.080 |
Why?
|
Cardiology | 2 | 2024 | 1658 | 0.080 |
Why?
|
Intestinal Perforation | 1 | 1991 | 252 | 0.080 |
Why?
|
Health Care Costs | 2 | 2019 | 3203 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1768 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2020 | 3801 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 783 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 552 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1541 | 0.070 |
Why?
|
Markov Chains | 2 | 2020 | 969 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3070 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1636 | 0.070 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 1095 | 0.070 |
Why?
|
HIV | 2 | 2023 | 1600 | 0.070 |
Why?
|
Models, Statistical | 1 | 2020 | 5100 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2015 | 3067 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1436 | 0.060 |
Why?
|
North America | 2 | 2019 | 1249 | 0.060 |
Why?
|
Germany | 1 | 2006 | 860 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2450 | 0.060 |
Why?
|
Cost Control | 1 | 2006 | 624 | 0.060 |
Why?
|
Automation | 2 | 2017 | 584 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8925 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 8969 | 0.060 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 681 | 0.060 |
Why?
|
ROC Curve | 3 | 2015 | 3528 | 0.060 |
Why?
|
Cohort Studies | 6 | 2022 | 40450 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12242 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2021 | 77098 | 0.050 |
Why?
|
Disease Progression | 4 | 2021 | 13256 | 0.050 |
Why?
|
Time Factors | 6 | 2020 | 40054 | 0.050 |
Why?
|
Public Policy | 1 | 2006 | 572 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9826 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 9941 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2789 | 0.050 |
Why?
|
Area Under Curve | 2 | 2015 | 1653 | 0.050 |
Why?
|
Observer Variation | 2 | 2018 | 2593 | 0.050 |
Why?
|
Prevalence | 4 | 2019 | 15194 | 0.050 |
Why?
|
Biliary Fistula | 1 | 1999 | 36 | 0.040 |
Why?
|
Decision Support Techniques | 2 | 2020 | 1952 | 0.040 |
Why?
|
Health Policy | 2 | 2015 | 2657 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2017 | 1183 | 0.040 |
Why?
|
Bronchial Fistula | 1 | 1999 | 85 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 730 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1118 | 0.040 |
Why?
|
United States | 7 | 2019 | 69693 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4554 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5385 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12958 | 0.040 |
Why?
|
Health Care Reform | 1 | 2006 | 1261 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2019 | 5062 | 0.040 |
Why?
|
Hospitalization | 4 | 2017 | 10232 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6534 | 0.040 |
Why?
|
Acute Disease | 2 | 2017 | 7141 | 0.040 |
Why?
|
Adult | 10 | 2021 | 213712 | 0.040 |
Why?
|
Hepatectomy | 1 | 1999 | 550 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 547 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13019 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14720 | 0.030 |
Why?
|
Boston | 2 | 2020 | 9305 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39004 | 0.030 |
Why?
|
Registries | 2 | 2022 | 8077 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 925 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4214 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 923 | 0.030 |
Why?
|
Duodenoscopy | 1 | 1993 | 52 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9846 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1661 | 0.030 |
Why?
|
Sex Factors | 2 | 2017 | 10392 | 0.030 |
Why?
|
Duodenoscopes | 1 | 1993 | 44 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10578 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2017 | 926 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12344 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1679 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1517 | 0.030 |
Why?
|
Electrocoagulation | 1 | 1993 | 158 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3199 | 0.030 |
Why?
|
Software | 2 | 2017 | 4434 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1215 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21596 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1847 | 0.020 |
Why?
|
Models, Psychological | 1 | 2015 | 810 | 0.020 |
Why?
|
Contrast Media | 2 | 2015 | 5295 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13403 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3510 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4554 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1224 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1483 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1806 | 0.020 |
Why?
|
Gadolinium | 1 | 2015 | 951 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2749 | 0.020 |
Why?
|
American Heart Association | 1 | 2014 | 1055 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1107 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2015 | 35342 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2015 | 1572 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1991 | 15244 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2015 | 1520 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7276 | 0.020 |
Why?
|
Primary Prevention | 1 | 2015 | 1166 | 0.020 |
Why?
|
Patient Admission | 1 | 2015 | 1380 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2145 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6891 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2014 | 1927 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6483 | 0.020 |
Why?
|
Survivors | 1 | 2015 | 2286 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.020 |
Why?
|
Mass Screening | 1 | 2019 | 5238 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7901 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2017 | 3258 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16331 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10372 | 0.010 |
Why?
|
Colon | 1 | 1991 | 1773 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3740 | 0.010 |
Why?
|
Echocardiography | 1 | 2015 | 5097 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3300 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57683 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5304 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18355 | 0.010 |
Why?
|
Cholangiography | 1 | 1999 | 189 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
Recurrence | 1 | 1991 | 8333 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 12730 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1999 | 504 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 24913 | 0.010 |
Why?
|
Stroke | 1 | 2017 | 9963 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13853 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 62966 | 0.010 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_